The transcriptomic analysis of purely sorted Tregs and Tconvs identified CD80-expressing Tregs as a subpopulation of Tregs associated to bad prognosis in breast cancer, which represents a candidate for the design of immunoregulatory therapies, and merit further analysis to better understand its role in the biology of tumor-associated Tregs. The gene discussed is CD80; the disease is breast cancer.